Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

VENUS REMEDIES LTD.

NSE : VENUSREMBSE : 526953ISIN CODE : INE411B01019Industry : Pharmaceuticals & DrugsHouse : Private

BSE897.4032.3 (+3.73 %)

PREV CLOSE ( ) 865.10

OPEN PRICE ( ) 860.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 16603

TODAY'S LOW / HIGH ( )844.00 908.35

52 WK LOW / HIGH ( )285.8 950

NSE896.6035.55 (+4.13 %)

PREV CLOSE( ) 861.05

OPEN PRICE ( ) 833.60

BID PRICE (QTY) 896.60 (68)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 94779

TODAY'S LOW / HIGH( ) 831.10 904.10

52 WK LOW / HIGH ( )285.7 944.75

Quarters

Select year

( in Million)

Particulars

Dec 2025

Sep 2025

Jun 2025

Mar 2025

Audited / UnAudited

UnAudited

Net Sales

1802.6

1927.5

1319

1949.7

Total Expenditure

1427.4

1617.9

1218

1659.7

PBIDT (Excl OI)

375.2

309.6

101

290

Other Income

25.2

17.1

86.9

67.6

Operating Profit

400.4

326.7

187.9

357.6

Interest

0.1

Exceptional Items

0.00

PBDT

400.3

326.6

187.8

357.5

Depreciation

65.6

61.7

61.8

47.1

Profit Before Tax

334.7

264.9

126

310.4

Tax

78.9

63.6

100.4

Provisions and contingencies

Profit After Tax

255.8

201.3

96.00

210

Extraordinary Items

Prior Period Expenses

Other Adjustments

Net Profit

255.8

201.3

96.00

210

Minority Interest

Shares of Associates

Other related items

Misc. Expenses Written off

Consolidated Net Profit

255.8

201.3

210

Equity Capital

133.7

Face Value (IN RS)

Reserves

Calculated EPS

19.13

15.05

7.18

15.70

Calculated EPS (Annualised)

76.52

60.22

28.72

62.82

No of Public Share Holdings

7784991

% of Public Share Holdings

58.24

PBIDTM% (Excl OI)

20.81

16.06

7.65

14.87

PBIDTM%

22.21

16.94

14.24

18.34

PBDTM%

22.20

16.94

14.23

18.33

PBTM%

18.56

13.74

9.55

15.92

PATM%

14.19

10.44

7.27

10.77

Notes

Risk Disclosures on Derivatives

Quarterly Results

VENUS REMEDIES LTD.